Ursolic acid inhibits Th17 cell differentiation via STAT3/RORγt pathway and suppresses Schwann cell-mediated Th17 cell migration by reducing CXCL9/10 expression
Innate Immunity · 2022-07 · 28 (5) · 155-163
DOI: 10.1177/17534259221094559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innate Immunity, online erschienen am 12.05.2022. Verfasst von Hua Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan 250014, …. Hauptthemen laut MEDLINE: Chemokine CXCL10, Chemokine CXCL9, Nuclear Receptor Subfamily 1, Group F, Member 3, STAT3 Transcription Factor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, the sci-tech development project of medicine and health in Shandong province.
Abstract (Originalsprache)
Th17 cells represent important immune cells. Ursolic acid (UA) can regulate immune cell activities. This study was aimed to explore the effects of UA on Th17 cell differentiation and Schwann cell(SCs)-mediated migration and the potential mechanism. Naïve CD4 + T cells were isolated from rat peripheral blood, induced for Th17 cell differentiation, and treated with UA. The proportion of Th17 cells was detected by flow cytometry assay. SCs were co-cultured with Th17 cells. Th17 cell migration was detected by Transwell assay. The molecule expression was determined by Western blot and qRT-PCR. UA inhibited the Th17 cell differentiation and suppressed the STAT3/RORγt pathway. STAT3 overexpression up-regulated p-STAT3 and RORγt expression and promoted Th17 cell differentiation under the UA treatment. In LPS- and IFN-γ-stimulated-SCs, UA suppressed the expression of chemokines CXCL9/10, but had no significant effect of CCL20 expression. The expression CXCL9/10 receptor CXCR3 was higher in Th17 cells than that in Treg cells, while the expression CCL20 receptor CCR6 was lower in Th17 cells than that in Treg cells. UA, anti-CXCR3, and anti-CCR6 treatment inhibited SCs-mediated Th17 cell migration, and anti-CXCR3 exerted stronger inhibitory effect than Anti-CCR6. UA inhibited Th17 cell differentiation through STAT3/RORγt pathway and suppressed Th17 cell migration through down-regulating CXCL9/10 expression in SCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan 250014, Shandong, China.
- Department of Neurology, 230965Taian City Central Hospital, Taian 271000, Shandong, China.
- Clinical laboratory, 230965Taian City Central Hospital, Taian 271000, Shandong, China.
- Department of Hematology, 230965Taian City Central Hospital, Taian 271000, Shandong, China.
ORCID-Profile: Hua Xu
Förderung
- National Natural Science Foundation of China
- the sci-tech development project of medicine and health in Shandong province
Zitieren
APA
Xu, H., Yu, A. L., Zhao, D. P., Meng, G. Y., Wang, L., Shan, M., Hu, N. X., & Liu, Y. L. (2022). Ursolic acid inhibits Th17 cell differentiation via STAT3/RORγt pathway and suppresses Schwann cell-mediated Th17 cell migration by reducing CXCL9/10 expression. Innate Immunity, 28(5), 155-163. https://doi.org/10.1177/17534259221094559
Vancouver
Xu H, Yu AL, Zhao DP, Meng GY, Wang L, Shan M, et al. Ursolic acid inhibits Th17 cell differentiation via STAT3/RORγt pathway and suppresses Schwann cell-mediated Th17 cell migration by reducing CXCL9/10 expression. Innate Immunity. 2022;28(5):155-163. doi:10.1177/17534259221094559
BibTeX
@article{Xu2022,
author = {Xu, Hua and Yu, Ai-Ling and Zhao, Da-Peng and Meng, Guang-Yuan and Wang, Ling and Shan, Min and Hu, Nai-Xia and Liu, Yun-Lin},
title = {Ursolic acid inhibits Th17 cell differentiation via STAT3/RORγt pathway and suppresses Schwann cell-mediated Th17 cell migration by reducing CXCL9/10 expression},
journal = {Innate Immunity},
year = {2022},
volume = {28},
number = {5},
pages = {155--163},
doi = {10.1177/17534259221094559}
}
EUVIMED